BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11338045)

  • 1. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme.
    Fernández A; Cortés M; Benito E; Azpeitia D; Prieto L; Moreno A; Ricart Y; Mora J; Escobedo A; Martín Comín J
    Nucl Med Commun; 2001 Apr; 22(4):361-6. PubMed ID: 11338045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
    Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.
    Valdés Olmos RA; Tanis PJ; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kooi ML; Kroon BB
    Nucl Med Commun; 2001 May; 22(5):579-86. PubMed ID: 11388582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node localization in patients with non-palpable breast cancer.
    Fernandez A; Escobedo A; Benito E; Azpeitia D; Guma A; Prieto L; Moreno A; Martin-Comin J
    Nucl Med Commun; 2002 Dec; 23(12):1165-9. PubMed ID: 12464780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
    J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study.
    Koizumi M; Nomura E; Yamada Y; Takiguchi T; Tanaka K; Yoshimoto M; Makita M; Sakamoto G; Kasumi F; Ogata E
    Nucl Med Commun; 2003 Jun; 24(6):663-70. PubMed ID: 12766602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sentinel lymph node biopsy in breast cancer: the Lausanne experience].
    Delaloye JF; Antonescu C; Besseghir N; Genton CY; Bischof-Delaloye A; De Grandi P
    Rev Med Suisse Romande; 2000 Jun; 120(6):491-4. PubMed ID: 11014092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphic sentinel node imaging and gamma probe detection in breast cancer with Tc-99m nanocolloidal albumin: results of an optimized protocol.
    Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
    Clin Nucl Med; 2001 Apr; 26(4):293-8. PubMed ID: 11290886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.
    Sanjuàn A; Vidal-Sicart S; Zanón G; Pahisa J; Velasco M; Fernández PL; Santamaría G; Farrús B; Muñoz M; Albanell J; Pons F; Vanrell JA
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):932-6. PubMed ID: 15791433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P; Ibis E; Aras G; Cam R; Küçük NO
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.